Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Proffitt

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|November 24, 2005
Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafunginJon A Olson, Jill P Adler-Moore, P J Smith, et al.
Journal of Liposome Research|May 9, 2017
Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimensJ P Adler-Moore, R T Proffitt, J A Olson, et al.
Royal Society Open Science|April 17, 2018
Analysis of wild macaque stone tools used to crack oil palm nutsT Proffitt, V L Luncz, S Malaivijitnond, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1991
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodentsR T Proffitt, A Satorius, S M Chiang, et al.
Biochemical and Biophysical Research Communications|November 3, 1975
Liver peptide stabilizing factor protects phosphofructokinase against inactivation by fructose-1,6-bisphosphataseL Sankaran, R T Proffitt, B M Pogell, et al.
The Journal of Biological Chemistry|February 25, 1980
Regulation of the synthesis of S-100 protein in rat glial cellsR Gysin, B W Moore, R T Proffitt, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis modelJon A Olson, Jill P Adler-Moore, Julie Schwartz, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infectionsJon A Olson, Ancy George, David Constable, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infectionsJ A Olson, J Schwartz, D Hahka, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2007
Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin BPeter J Smith, Jon A Olson, David Constable, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|November 24, 2005
Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafunginJon A Olson, Jill P Adler-Moore, P J Smith, et al.
Journal of Liposome Research|May 9, 2017
Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimensJ P Adler-Moore, R T Proffitt, J A Olson, et al.
Royal Society Open Science|April 17, 2018
Analysis of wild macaque stone tools used to crack oil palm nutsT Proffitt, V L Luncz, S Malaivijitnond, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1991
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodentsR T Proffitt, A Satorius, S M Chiang, et al.
Biochemical and Biophysical Research Communications|November 3, 1975
Liver peptide stabilizing factor protects phosphofructokinase against inactivation by fructose-1,6-bisphosphataseL Sankaran, R T Proffitt, B M Pogell, et al.
The Journal of Biological Chemistry|February 25, 1980
Regulation of the synthesis of S-100 protein in rat glial cellsR Gysin, B W Moore, R T Proffitt, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis modelJon A Olson, Jill P Adler-Moore, Julie Schwartz, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2010
Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infectionsJon A Olson, Ancy George, David Constable, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infectionsJ A Olson, J Schwartz, D Hahka, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2007
Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin BPeter J Smith, Jon A Olson, David Constable, et al.
Pageof 5